Results 301 to 310 of about 898,653 (339)

Cardiogenic Shock in Restrictive Cardiomyopathies: What We Know So Far. [PDF]

US Cardiol
Abou Hassan OK, Chukwu E, Schmittner J, Khariton Y, Bahe MP, Peltak ME, Smith C, Nikolaidis L, Kuriakose E, Wencker D, Hernandez-Montfort J.   +10 more
europepmc   +1 more source

Differences in the characteristics and outcomes of STEMI versus NSTEMI cardiogenic shock: A systematic review and meta-analysis. [PDF]

Medicine (Baltimore)
Sheng Z, Chen B.
europepmc   +1 more source

2025 ACVIM Forum Research Abstract Program

Journal of Veterinary Internal Medicine, Volume 39, Issue 6, November/December 2025.
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Extracorporeal Life Support in Infarct-Related Cardiogenic Shock.

New England Journal of Medicine, 2023
BACKGROUND Extracorporeal life support (ECLS) is increasingly used in the treatment of infarct-related cardiogenic shock despite a lack of evidence regarding its effect on mortality.
H. Thiele, U. Zeymer, I. Akin, M. Behnes, T. Rassaf, A. Mahabadi, R. Lehmann, I. Eitel, T. Graf, Tim Seidler, Andreas Schuster, Carsten Skurk, D. Duerschmied, P. Clemmensen, M. Hennersdorf, S. Fichtlscherer, I. Voigt, M. Seyfarth, Stefan John, S. Ewen, A. Linke, E. Tigges, P. Nordbeck, Leonhard Bruch, C. Jung, Jutta Franz, P. Lauten, Tomaz Goslar, H. Feistritzer, Janine Pöss, Eva Kirchhof, T. Ouarrak, Steffen Schneider, S. Desch, A. Freund   +34 more
semanticscholar   +1 more source

Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC)

Circulation, 2023
The Shock Academic Research Consortium is a multi-stakeholder group, including representatives from the US Food and Drug Administration and other government agencies, industry, and payers, convened to develop pragmatic consensus definitions useful for ...
R. Waksman, M. Pahuja, Sean van Diepen, A. Proudfoot, D. Morrow, Ernest Spitzer, Graham Nichol, M. Weisfeldt, Mauro Moscucci, P. Lawler, Alexandre Mebazaa, E. Fan, Neal W. Dickert, Marc D. Samsky, R. Kormos, Ileana L. Piña, Bram D. Zuckerman, Andrew Farb, J. Sapirstein, Charles Simonton, N. E. West, Abdulla A. Damluji, Ian C. Gilchrist, U. Zeymer, H. Thiele, D. Cutlip, Mitchell W. Krucoff, William T. Abraham   +27 more
semanticscholar   +1 more source

Prognostic value of Intermountain Risk Score for short- and long-term mortality in patients with cardiogenic shock

Coronary Artery Disease, 2023
Background There is a lack of current research examining the predictive value of the Intermountain Risk Score (IMRS) in patients with ST-segment elevation myocardial infarction (STEMI) caused by cardiogenic shock.
Hayıroğlu Mert İlker, Saylik Faysal, Yumurtaş Ahmet Çağdaş, Selçuk Murat, Çinar Tufan   +4 more
semanticscholar   +1 more source

Advances in the Management of Cardiogenic Shock

Critical Care Medicine, 2023
OBJECTIVES: To review a contemporary approach to the management of patients with cardiogenic shock (CS). DATA SOURCES: We reviewed salient medical literature regarding CS.
J. Jentzer, Janine Pöss, H. Schaubroeck, D. Morrow, S. Hollenberg, A. Mebazaa   +5 more
semanticscholar   +1 more source